Onconova Therapeutics, Inc. (ONTX) has 69 open-market insider trades by 20 insiders since 2013. The most active filer is Tyndall Capital Partners L P, 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Michael B. Hoffman | Dir | — | 6 | $15.5M | 2020-08-27 |
| & Jane Hoffman 2013 Descendants Michael | 10% | — | 4 | $15.4M | 2014-02-21 |
| Tyndall Capital Partners L P | 10% Owner | — | 11 | $10.4M | 2019-09-24 |
| 683 Capital Management, LLC | 10% Owner | — | 1 | $10.2M | 2018-04-27 |
| Healthcare Sa Baxter | 10% | — | 1 | $5.0M | 2015-05-06 |
| Ari Zweiman | 10% Owner | — | 1 | $1.8M | 2019-09-18 |
| E. Premkumar Reddy | Dir | — | 6 | $1.3M | 2020-08-27 |
| Viren Mehta | Dir | — | 2 | $300K | 2019-11-25 |
| 683 Capital Partners, LP via Ari Zweiman | 10% Owner | — | 1 | $208K | 2018-02-08 |
| Ramesh Kumar | CEOPres | — | 3 | $163K | 2017-04-26 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Abraham N. Oler | SVP Corp Dev & Gen Counsel | Buy | $3K | 2022-01-28 |
| Abraham N. Oler | SVP Corp Dev & Gen Counsel | Buy | $3K | 2022-01-21 |
| Abraham N. Oler | SVP CORP DEV & GEN COUNSEL | Buy | $3K | 2022-01-14 |
| Abraham N. Oler | SVP Corp Dev & Gen Counsel | Buy | $4K | 2022-01-07 |
| Abraham N. Oler | SVP CORP DEV & GEN COUNSEL | Buy | $3K | 2021-11-19 |
| Mark S. Gelder M.D. | Chief Medical Officer | Buy |
Companies that share insiders with ONTX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| $10K |
| 2021-09-28 |
| James J. Marino | Director | Buy | $25K | 2021-09-28 |
| Steven M. Fruchtman | President & Chief Executive Off | Buy | $20K | 2021-02-16 |
| Abraham N. Oler | SVP Corp Dev & Gen Counsel | Buy | $12K | 2021-02-16 |
| Mary Teresa Shoemaker | Director | Buy | $13K | 2021-02-16 |
| Mark Patrick Guerin | CFO | Buy | $15K | 2021-02-16 |
| James J. Marino | Director | Buy | $25K | 2021-02-16 |
| Abraham N. Oler | SVP Corp Dev & Gen Counsel | Buy | $10K | 2020-12-11 |
| Mary Teresa Shoemaker | Director | Buy | $10K | 2020-11-25 |
| Mark Patrick Guerin | CFO | Buy | $6K | 2020-11-25 |